Venturi Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Venturi Wealth Management's ARKG Position: Q1 2025 in Review
Venturi Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 100 shares — an estimated $2.35K sold.
Venturi Wealth Management first reported a position in ARKG in Q1 2023 and held it in 8 quarters. The position peaked at $7.5K in Q2 2023. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.
- Venturi Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
- Venturi Wealth Management sold 100 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $2.35K.
- Venturi Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 8 quarters.
- Venturi Wealth Management's ARK Genomic Revolution ETF position peaked at $7.5K in Q2 2023.
- 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.
Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.